Centron, a full-service, wholly integrated healthcare communications firm and recipient of Med Ad News Agency of the Year in 2016, announced the appointment of David Stolzer as Senior Vice President, Digital Strategy and Innovation.

Kite Pharma Inc. today highlighted a publication in the latest issue of Nature Methods that describes pre-clinical findings demonstrating that a novel serum-free, 3-dimensional cell culture technology, known as the Artificial Thymic Organoid (ATO) cell culture system, recapitulates T-cell differentiation.